| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 29, 2005
Accepted on December 13, 2005
Unit of Paediatrics, Department of Medical Sciences, Eastern Piedmont University, Novara, Italy; Department of Paediatrics, L. Sacco Hospital, University of Milan, Italy; Laboratory of Human Genetics, Department of Medical Sciences, Eastern Piedmont University and IRCAD (Interdisciplinary Research Center on Autoimmune Diseases), Novara, Italy
* To whom correspondence should be addressed. E-mail: giordano{at}med.unipmn.it.
Context: The majority of mutations responsible for IGHD II lead to dominant negative deleteriously increased levels of the GH1 exon 3 skipped transcripts.
Objective: The aim of this study was the characterization of the molecular defect causing a familial case of IGHD II.
Patients: A 2 yr old child and her mother with severe growth failure at diagnosis (-5.8 SDS and -6.9 SDS respectively) and IGHD were investigated for the presence of GH1 mutations.
Results: We identified a novel 22 bp deletion in IVS3 (IVS3 del+56-77) removing the putative branch point sequence (BPS). Analysis of patients' lymphocyte mRNA showed an excess exon 3 skipping. The mutated allele transfected into rat pituitary cells produced four differently spliced products: the exon 3 skipped mRNA as the main product and lower amounts of the full-length cDNA and of two novel mRNA aberrant isoforms, one deleted of the first 86 bases of exon 4 and the other lacking the entire exon 4. A mutagenized construct lacking exclusively the 7 pb of the BPS only generated the exon 4 skipped and the full-length isoforms. The presence of the full lenght transcript in the absence of the canonical BPS, points to an alternative BPS in IVS3.
Conclusion: The IVS3 del+56-77 mutation, causing IGHD II in this family, has two separate effects on mRNA processing : i) exon 3 skipping, analogous to most described cases of IGHD II. This effect is likely caused by the reduction in size of the IVS3. ii) partial or total exon 4 skipping, due to the removal of the BPS.
This article has been cited by other articles:
![]() |
S. Salemi, S. Yousefi, D. Lochmatter, A. Eble, J. Deladoey, I. C. A. F. Robinson, H.-U. Simon, and P. E. Mullis Isolated Autosomal Dominant Growth Hormone Deficiency: Stimulating Mutant GH-1 Gene Expression Drives GH-1 Splice-Site Selection, Cell Proliferation, and Apoptosis Endocrinology, January 1, 2007; 148(1): 45 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pfaffle Genetics of growth in the normal child Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S27 - S33. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |